McLoughlin Dennis 4
4 · Pacira BioSciences, Inc. · Filed Jun 7, 2023
Insider Transaction Report
Form 4
McLoughlin Dennis
Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-06-06$38.99/sh−1,014$39,537→ 39,172 total - Sale
Common Stock
2023-06-07$37.87/sh−1,057$40,023→ 38,115 total
Footnotes (2)
- [F1]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- [F2]Includes an aggregate of 416 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022 and December 2022.